Physician profile
Daniel Brent Box
NPI 1083970198
$3,726.87
in general payments reported to CMS, 2019-2025
31 companies · $513 in 2025
The $513 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $454 · 2021: $28.00 · 2022: $226 · 2023: $1,270 · 2024: $1,100 · 2025: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,681 · Travel and Lodging: $1,167 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,681.43 |
| Travel and Lodging | $1,166.56 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,714.93 | 2022-2025 | Tactra, Ams 700, Rezum Generator |
| Intuitive Surgical, INC. | $407.49 | 2020 | |
| Medtronic, INC. | $188.43 | 2023-2025 | Interstim, Altaviva |
| Procept Biorobotics Corporation | $185.37 | 2024-2025 | Aquabeam System |
| Sumitomo Pharma America, INC. | $158.25 | 2023-2025 | Gemtesa, Orgovyx |
| Teleflex LLC | $158.10 | 2022-2024 | Urolift |
| Janssen Biotech, INC. | $124.77 | 2023-2025 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $124.64 | 2019-2023 | |
| Dendreon Pharmaceuticals LLC | $53.18 | 2019-2021 | |
| Laborie Medical Technologies Corp. | $50.49 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Coloplast Corp | $47.66 | 2024 | |
| Rochester Medical Corporation | $44.12 | 2022 | |
| Abbvie INC. | $43.19 | 2019-2024 | |
| Calyxo, INC. | $40.80 | 2025 | Cvac Aspiration System |
| Accord Healthcare, INC. | $39.31 | 2025 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $38.89 | 2019-2024 | |
| Photocure INC | $36.96 | 2023-2025 | Cysview |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Endo Pharmaceuticals INC. | $33.21 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $23.23 | 2024 | Bridion |
| Conmed Corporation | $21.21 | 2023 | Airseal |
| Sun Pharmaceutical Industries INC. | $18.71 | 2024 | |
| Blue Earth Diagnostics | $18.65 | 2019 | |
| Urovant Sciences INC | $18.29 | 2022 | |
| Travere Therapeutics, INC. | $18.19 | 2020 | |
| Caldera Medical, INC | $17.01 | 2025 | |
| Astellas Pharma US INC | $15.25 | 2023 | Myrbetriq |
| Olympus America INC. | $14.99 | 2025 | Itind System |
| Ferring Pharmaceuticals INC. | $12.98 | 2019 | |
| Medtronic USA, INC. | $11.99 | 2019 | |
| Zyla Life Sciences, INC. | $11.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Box listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.